title: [Avene-50 and Ebastine in treatment and prevention of photodermatosis].
abstract: The clinical efficacy of antihistaminic preparation "Kestine" (Ebastine) in combined treatment of 50 patients suffering from photo-allergic dermatosis (15 - solar urticaria, 20 - solar erythema and 15 - solar eczema) are evaluated. Kestine in dosage of 10 mg a day was prescribed in duration of 10 days. Itch disappearance was observed in 87% of patients, reduction of itching - in 10% and in 3% of patients an itch was remain. Photo protector Avene-50 as sunburn preparation, assigned for different type of skins, has been used. This preparation fit for different demands (including prevention of both beginnings and exacerbation of photo allergic reactions) of patients. Water- and sweat-resistance of Avene-50 formula has been taken in account. Treatment caused increasing of some indices of non specific reactions (Kavetski skin test) that confirms recovery of conjunctive tissue elements' activity. Efficacy and safety of this combined method of photodermatosis treatment allow us to use it widely in dermatologic clinic.
authors.forename: N V
authors.initials: NV
authors.lastname: Tsiskarishvili
authors.forename: M M
authors.initials: MM
authors.lastname: Dundua
authors.forename: N I
authors.initials: NI
authors.lastname: Tsiskarishvili
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002090:Butyrophenones / Q000627:therapeutic use*; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008900:Mineral Waters / Q000627:therapeutic use; D010787:Photosensitivity Disorders / Q000517:prevention & control / Q000628:therapy*; D010880:Piperidines / Q000627:therapeutic use*; D013473:Sunscreening Agents / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D002090:Butyrophenones; D006634:Histamine H1 Antagonists; D008900:Mineral Waters; D010880:Piperidines; D013473:Sunscreening Agents; C058249:ebastine